| Does endothelial dysfunction contribute to the clinical status of patients with peripheral arterial disease? | |
| | |
MedLine Citation:
|
PMID: 20386761 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Peripheral arterial disease leads to lower extremity ischemia and limb loss, and is linked to cardiovascular events. The anatomical extent of lower extremity atherosclerosis fails to fully explain ischemic symptoms or predict the development of critical limb ischemia. Endothelial dysfunction is known to contributed to the pathogenesis and clinical expression of coronary artery disease, but the importance of endothelial dysfunction in peripheral arterial disease remains incompletely understood. Endothelial dysfunction could contribute to lower extremity ischemia by impairing blood flow responses to ischemia, collateral formation and arterial remodelling, and by promoting vasospasm, thrombosis, plaque rupture and lesion progression. There is a need for additional studies examining the contribution of endothelial dysfunction to the pathogenesis of peripheral arterial disease, and the potential role of endothelial dysfunction as a surrogate marker with utility in the management of patients. |
| | |
Authors:
|
Joseph A Vita; Naomi M Hamburg |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: The Canadian journal of cardiology Volume: 26 Suppl A ISSN: 1916-7075 ISO Abbreviation: Can J Cardiol Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-04-13 Completed Date: 2010-05-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8510280 Medline TA: Can J Cardiol Country: Canada |
Other Details:
|
Languages: eng Pagination: 45A-50A Citation Subset: IM |
Affiliation:
|
Evans Department of Medicine and Whitake Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, USA. jvita@bu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biological Markers
/
blood Endothelium, Vascular / physiopathology* Humans Lower Extremity / blood supply* Peripheral Vascular Diseases / physiopathology* Regional Blood Flow |
| Grant Support | |
ID/Acronym/Agency:
|
1UL1RR025771/RR/NCRR NIH HHS; HL081587/HL/NHLBI NIH HHS; HL083269/HL/NHLBI NIH HHS; HL083801/HL/NHLBI NIH HHS; HL75795/HL/NHLBI NIH HHS; K12 HL083781/HL/NHLBI NIH HHS; K12 HL083781-01/HL/NHLBI NIH HHS; K12 HL083781-02/HL/NHLBI NIH HHS; K12 HL083781-03/HL/NHLBI NIH HHS; K12 HL083781-04/HL/NHLBI NIH HHS; P01 HL081587-010005/HL/NHLBI NIH HHS; P01 HL081587-020005/HL/NHLBI NIH HHS; P01 HL081587-030005/HL/NHLBI NIH HHS; P01 HL081587-040005/HL/NHLBI NIH HHS; P01 HL081587-050005/HL/NHLBI NIH HHS; P50 HL083801-01/HL/NHLBI NIH HHS; P50 HL083801-017464/HL/NHLBI NIH HHS; P50 HL083801-02/HL/NHLBI NIH HHS; P50 HL083801-03/HL/NHLBI NIH HHS; P50 HL083801-04/HL/NHLBI NIH HHS; P50 HL083801-05/HL/NHLBI NIH HHS; R01 HL075795-01/HL/NHLBI NIH HHS; R01 HL075795-02/HL/NHLBI NIH HHS; R01 HL075795-03/HL/NHLBI NIH HHS; R01 HL075795-05/HL/NHLBI NIH HHS; R01 HL083269-01A1/HL/NHLBI NIH HHS; R01 HL083269-02/HL/NHLBI NIH HHS; R01 HL083269-03/HL/NHLBI NIH HHS; R01 HL083269-04/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: C-reactive protein: risk factor, biomarker and/or therapeutic target?
Next Document: Current status of cardiovascular magnetic resonance imaging in the assessment of coronary vasculatur...